Case Study: Patient with Long COVID
Post-Acute Sequelae of SARS-CoV-2 (PASC), or Long COVID, is a major public health problem. We reported a case of breakthrough PASC and its resolution following a course of the
3CL protease inhibitor dietary supplement Tollovid®.
A 49-year-old female presented with COVID-19 symptoms of lethargy, persistent positive tests and inability to return to work since she was discharged from the hospital after a short admission with COVID-19. While in the hospital the doctors started her on Standard COVID-19 protocols and discharged her 7 days later with instructions to use home oxygen until she felt better. She weaned herself off of oxygen after 7 days, but she was still unable to return to work due to weakness and a positive COVID-19 nasal PCR test. She suffered from low energy, excessive somnolence, easy fatigability, myalgia, and headaches. A series of blood tests revealed no abnormal findings. However, she persisted in testing positive for COVID-19 on nasal swab specimens. She took a nasopharyngeal swab COVID-19 test every other week for 12 weeks. During this period, she consulted with two physicians who prescribed her acetaminophen and ibuprofen.
After a thorough review of her history, Dr. John Mabayoje concluded that she had long COVID, or what doctors refer to as post-acute sequelae of COVID-19 (PASC) , also known as Long Hauler syndrome. Dr. Mabayoje sent her a bottle of commercially available dietary supplement Tollovid that contained 60 capsules and instructed her to take 3 capsules every 6 hours for 5 consecutive days. She responded to the supplement and all of her symptoms were eliminated in 1 week. At the end of the week she tested negative by PCR. She resumed work again after an absence of almost 3 months and has not experienced any COVID or PASC symptoms for 4 months.
All of her symptoms
were eliminated in
She resumed work again after an absence of almost
She has not experienced any symptoms of COVID for